112 related articles for article (PubMed ID: 8880073)
1. Behavioural and immunological effects of the antihistamine terfenadine in olfactory bulbectomized rats.
Song C; Earley B; Leonard BE
Eur Neuropsychopharmacol; 1996 Aug; 6(3):157-62. PubMed ID: 8880073
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat.
Song C; Leonard BE
Neuroimmunomodulation; 1995; 2(5):263-73. PubMed ID: 8739199
[TBL] [Abstract][Full Text] [Related]
3. The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression.
Song C; Earley B; Leonard BE
Brain Behav Immun; 1996 Mar; 10(1):1-16. PubMed ID: 8735565
[TBL] [Abstract][Full Text] [Related]
4. Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression.
Redmond AM; Kelly JP; Leonard BE
Pharmacol Biochem Behav; 1997 Oct; 58(2):355-9. PubMed ID: 9300592
[TBL] [Abstract][Full Text] [Related]
5. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment.
Connor TJ; Harkin A; Kelly JP; Leonard BE
Neuroimmunomodulation; 2000; 7(1):27-35. PubMed ID: 10601816
[TBL] [Abstract][Full Text] [Related]
6. Tiagabine treatment is associated with neurochemical, immune and behavioural alterations in the olfactory bulbectomized rat model of depression.
Pistovcakova J; Dostalek M; Sulcova A; Jezova D
Pharmacopsychiatry; 2008 Mar; 41(2):54-9. PubMed ID: 18311685
[TBL] [Abstract][Full Text] [Related]
7. The determination of the optimal dose of milnacipran in the olfactory bulbectomized rat model of depression.
Redmond AM; Kelly JP; Leonard BE
Pharmacol Biochem Behav; 1999 Apr; 62(4):619-23. PubMed ID: 10208367
[TBL] [Abstract][Full Text] [Related]
8. Behavioural and neuropharmacological properties of the dibenzazepines, desipramine and lofepramine: studies on the olfactory bulbectomized rat model of depression.
O'Connor WT; Leonard BE
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(1):41-51. PubMed ID: 3363165
[TBL] [Abstract][Full Text] [Related]
9. The olfactory bulbectomized rat as a model of depression: an update.
Kelly JP; Wrynn AS; Leonard BE
Pharmacol Ther; 1997; 74(3):299-316. PubMed ID: 9352586
[TBL] [Abstract][Full Text] [Related]
10. The effects of chronic lithium chloride administration on some behavioural and immunological changes in the bilaterally olfactory bulbectomized rat.
Cai Song ; Leonard BE
J Psychopharmacol; 1994 Jan; 8(1):40-7. PubMed ID: 22298479
[TBL] [Abstract][Full Text] [Related]
11. Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat.
Roche M; Harkin A; Kelly JP
Neuropsychopharmacology; 2007 Jun; 32(6):1312-20. PubMed ID: 17119540
[TBL] [Abstract][Full Text] [Related]
12. The effect of tianeptine and sertraline in three animal models of depression.
Kelly JP; Leonard BE
Neuropharmacology; 1994 Aug; 33(8):1011-6. PubMed ID: 7531300
[TBL] [Abstract][Full Text] [Related]
13. H1-receptor blocker antihistamine, terfenadine durably influences the glucocorticoid receptor, and lymphocyte histamine content of weanling rats.
Csaba G; Inczefi-Gonda A; Kovács P; Pállinger E
Pharmacol Res; 2003 Sep; 48(3):241-4. PubMed ID: 12860441
[TBL] [Abstract][Full Text] [Related]
14. Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression.
Burke NN; Kerr DM; Moriarty O; Finn DP; Roche M
Brain Behav Immun; 2014 Nov; 42():147-56. PubMed ID: 24994592
[TBL] [Abstract][Full Text] [Related]
15. Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs.
van Riezen H; Schnieden H; Wren AF
Br J Pharmacol; 1977 Aug; 60(4):521-8. PubMed ID: 907867
[TBL] [Abstract][Full Text] [Related]
16. Desipramine administration in the olfactory bulbectomized rat: changes in brain beta-adrenoceptor and 5-HT2A binding sites and their relationship to behaviour.
Mudunkotuwa NT; Horton RW
Br J Pharmacol; 1996 Apr; 117(7):1481-6. PubMed ID: 8730743
[TBL] [Abstract][Full Text] [Related]
17. Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety.
Wang D; Noda Y; Tsunekawa H; Zhou Y; Miyazaki M; Senzaki K; Nabeshima T
Behav Brain Res; 2007 Mar; 178(2):262-73. PubMed ID: 17261334
[TBL] [Abstract][Full Text] [Related]
18. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
[TBL] [Abstract][Full Text] [Related]
19. Prolonged effect of an H1-receptor blocker antihistamine on the histamine content of white blood cells and mast cells.
Csaba G; Kovács P; Pállinger E
Cell Biochem Funct; 2004; 22(3):201-4. PubMed ID: 15124186
[TBL] [Abstract][Full Text] [Related]
20. The olfactory bulbectomized rat as a model of depression.
Leonard BE
Pol J Pharmacol Pharm; 1984; 36(5):561-9. PubMed ID: 6099892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
